Company Filing History:
1 out of 111 
1 out of 5,076 
1 out of 1,743 
Years Active: 2017
Title: Amélie Fouque: Innovator in Pharmaceutical Research
Introduction
Amélie Fouque is a notable inventor based in Neufbosc, France. He has made significant contributions to the field of pharmaceutical research, particularly in the development of inhibitors that target critical pathways in various diseases. His work has implications for the treatment of inflammatory and neurodegenerative diseases, among others.
Latest Patents
Amélie Fouque holds a patent for "PI3K/AKT/mTOR inhibitors and pharmaceutical uses thereof." This invention relates to new inhibitors that can be utilized for the prevention and treatment of diseases such as inflammatory diseases, autoimmune diseases, neurodegenerative diseases, cancers, transplant rejection, diseases characterized by premature aging, and tuberous sclerosis. He has 1 patent to his name.
Career Highlights
Throughout his career, Amélie has worked with prestigious institutions, including Université de Rennes 1 and the Centre National de la Recherche Scientifique. His research has been pivotal in advancing our understanding of disease mechanisms and potential therapeutic interventions.
Collaborations
Amélie has collaborated with notable colleagues, including Mickael Jean and Patrick Legembre. Their combined expertise has contributed to the success of various research projects and innovations in the pharmaceutical field.
Conclusion
Amélie Fouque's work exemplifies the impact of innovative research in addressing complex health challenges. His contributions to the development of PI3K/AKT/mTOR inhibitors highlight the importance of continued exploration in pharmaceutical sciences.